← Open Payments lookup

JULIE LOPES: Open Payments

NPI 1821358979 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$547 in 24 payments from 9 companies in 2025. Trend: 2023 $205 · 2024 $213 · 2025 $547

Food & beverage: $547
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$143
Otsuka America Pharmaceutical, Inc.5$120
Bayer Healthcare Pharmaceuticals Inc.4$114
UCB, Inc.1$36
GlaxoSmithKline, LLC.2$36
Dexcom, Inc.1$36
Amgen Inc.1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$21
Lundbeck LLC1$17

Products named: CAPLYTA, REXULTI, Kerendia, Briviact, Dexcom G6 Transmitter, Repatha, TRELEGY ELLIPTA, JARDIANCE.

Industry payments across CA — which companies pay providers there.